These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A steady-state evaluation of the bioavailability of chronotherapeutic oral drug absorption system verapamil PM after nighttime dosing versus immediate-acting verapamil dosed every eight hours. Prisant LM, Devane JG, Butler J. Am J Ther; 2000 Nov; 7(6):345-51. PubMed ID: 11304641 [Abstract] [Full Text] [Related]
24. Pharmacodynamic profile of verapamil in relation to absolute bioavailability: investigations with a conventional and a controlled-release formulation. Harder S, Thürmann P, Siewert M, Blume H, Huber T, Rietbrock N. J Cardiovasc Pharmacol; 1991 Feb; 17(2):207-12. PubMed ID: 1709224 [Abstract] [Full Text] [Related]
27. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption. Neuvonen PJ, Vartiainen M, Tokola O. Eur J Clin Pharmacol; 1983 Feb; 24(4):557-62. PubMed ID: 6134626 [Abstract] [Full Text] [Related]
31. Pharmacokinetics of verapamil and norverapamil in patients with hypertension: a comparison of oral conventional and sustained release formulations. Jørgensen NP, Walstad RA. Pharmacol Toxicol; 1988 Aug; 63(2):105-7. PubMed ID: 3186615 [Abstract] [Full Text] [Related]
32. Effect of activated charcoal on the absorption of amiodarone. Kivistö KT, Neuvonen PJ. Hum Exp Toxicol; 1991 Sep; 10(5):327-9. PubMed ID: 1683545 [Abstract] [Full Text] [Related]
34. [Bioavailability of two verapamil formulations following repeated administration in steady-state conditions. An open, two-period, crossover study]. Heintz B, Müller A, Lenhard G, Schütz M, Hutt HJ. Arzneimittelforschung; 1996 Nov; 46(11):1060-3. PubMed ID: 9065315 [Abstract] [Full Text] [Related]
35. Serum concentration and antihypertensive effect of slow-release verapamil. Schütz E, Ha HR, Bühler FR, Follath F. J Cardiovasc Pharmacol; 1982 Nov; 4 Suppl 3():S346-9. PubMed ID: 6184566 [Abstract] [Full Text] [Related]
36. The effects of charcoal and sorbitol (alone and in combination) on plasma theophylline concentrations after a sustained-release formulation. al-Shareef AH, Buss DC, Allen EM, Routledge PA. Hum Exp Toxicol; 1990 May; 9(3):179-82. PubMed ID: 2375885 [Abstract] [Full Text] [Related]
37. Oral bioavailability of dabigatran etexilate (Pradaxa(®) ) after co-medication with verapamil in healthy subjects. Härtter S, Sennewald R, Nehmiz G, Reilly P. Br J Clin Pharmacol; 2013 Apr; 75(4):1053-62. PubMed ID: 22946890 [Abstract] [Full Text] [Related]
38. Effect of activated charcoal administration on acetylcysteine serum levels in humans. North DS, Peterson RG, Krenzelok EP. Am J Hosp Pharm; 1981 Jul; 38(7):1022-4. PubMed ID: 7258201 [Abstract] [Full Text] [Related]
39. Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide. Neuvonen PJ, Kivistö K, Hirvisalo EL. Br J Clin Pharmacol; 1988 Feb; 25(2):229-33. PubMed ID: 3358884 [Abstract] [Full Text] [Related]